Clinical Trial Update: Evaluation of 611 in Chinese Children and Adolescents With Moderate to Severe Atopic Dermatitis [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating drug candidate 611 for moderate-to-severe atopic dermatitis in Chinese children and adolescents is currently active but no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• 611

Snippet

Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | Conditions: Dermatitis, Atopic | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING